NYMU Taipei/Part List
From 2007.igem.org
(Difference between revisions)
| Line 22: | Line 22: | ||
|- | |- | ||
|AU43-C7 | |AU43-C7 | ||
| - | |INS | + | |[http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=13528923 INS] |
| | | | ||
|human insulin | |human insulin | ||
Revision as of 09:44, 20 August 2007
| Series | alias | Circuit | Description | part length | plasmid (antibotics) |
|---|---|---|---|---|---|
| [http://partsregistry.org/Part:BBa_R0082 BBa_R0082] | pOmpC | 1 | Positively regulated, OmpR-controlled promoter | 108 | pSB1A2 |
| [http://partsregistry.org/Part:BBa_B0034 BBa_B0034] | RBS | 1,2,3 | The Elowitz RBS (Ribosome binding site) is the definition of efficiency 1.0 | 12 | pSB1A2 |
| AU43-C7 | [http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=13528923 INS] | human insulin | 495 | C | |
| INS_A | 1 | alpha chain of human insulin | 63 | ||
| INS_B | 1 | beta chain of human insulin | 90 | ||
| [http://partsregistry.org/Part:BBa_B0014 BBa_B0014] | D-term | 1,2,3 | Double translation terminator | 95 | pSB1AK3 |
| [http://partsregistry.org/Part:BBa_I14032 BBa_I14032] | pLacIQ | 2 | Constitutive Promoter, High Transcription | 37 | pSB2K3 |
| OmpRBS | 2 | OmpR binding sites | |||
| AV88-C6 | [http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=27371195 IDE] | 2 | insulin degradation enzyme of mouse | 3445 | A |
| AU61-F6 | IGFBP3 | 2 | Insulin-like growth factor binding protein 3 of human | 2488 | C |
| AU50-C7 | IGFBP7 | 2 | Insulin-like growth factor binding protein 7 of human | 1155 | C |
- antibiotics keys
- A: [http://en.wikipedia.org/wiki/Ampicillin Ampicillin]
- K: [http://en.wikipedia.org/wiki/Kanamycin Kanamycin]
- C: [http://en.wikipedia.org/wiki/Chloramphenicol Chloramphenicol]
